Development and validation of a highly sensitive and specific electrochemical assay to quantify anti-SARS-CoV-2 IgG antibodies to facilitate pandemic surveillance and monitoring of vaccine response.

MLA

Chiang, Samantha H., et al. “Development and Validation of a Highly Sensitive and Specific Electrochemical Assay to Quantify Anti-SARS-CoV-2 IgG Antibodies to Facilitate Pandemic Surveillance and Monitoring of Vaccine Response.” MedRxiv : The Preprint Server for Health Sciences, Nov. 2020. EBSCOhost, https://doi.org/10.1101/2020.11.12.20230656.

APA

Chiang, S. H., Tu, M., Cheng, J., Wei, F., Li, F., Chia, D., Garner, O., Chandrasekaran, S., Bender, R., Strom, C. M., & Wong, D. T. W. (2020). Development and validation of a highly sensitive and specific electrochemical assay to quantify anti-SARS-CoV-2 IgG antibodies to facilitate pandemic surveillance and monitoring of vaccine response. MedRxiv : The Preprint Server for Health Sciences. https://doi.org/10.1101/2020.11.12.20230656

Chicago

Chiang, Samantha H, Michael Tu, Jordan Cheng, Fang Wei, Feng Li, David Chia, Omai Garner, et al. 2020. “Development and Validation of a Highly Sensitive and Specific Electrochemical Assay to Quantify Anti-SARS-CoV-2 IgG Antibodies to Facilitate Pandemic Surveillance and Monitoring of Vaccine Response.” MedRxiv : The Preprint Server for Health Sciences, November. doi:10.1101/2020.11.12.20230656.